Free Trial

AbCellera Biologics (ABCL) Short Interest Ratio & Short Volume

AbCellera Biologics logo
$2.67 -0.04 (-1.48%)
(As of 11/20/2024 ET)

AbCellera Biologics Short Interest Data

AbCellera Biologics (ABCL) has a short interest of 16.64 million shares, representing 8.04% of the float (the number of shares available for trading by the public). This marks a -4.09% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.1, indicating that it would take 8.1 days of the average trading volume of 2.62 million shares to cover all short positions.

Current Short Interest
16,640,000 shares
Previous Short Interest
17,350,000 shares
Change Vs. Previous Month
-4.09%
Dollar Volume Sold Short
$45.43 million
Short Interest Ratio
8.1 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
295,370,000 shares
Float Size
207,080,000 shares
Short Percent of Float
8.04%
Today's Trading Volume
1,718,414 shares
Average Trading Volume
2,622,374 shares
Today's Volume Vs. Average
66%
Short Selling AbCellera Biologics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for AbCellera Biologics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ABCL Short Interest Over Time

ABCL Days to Cover Over Time

ABCL Percentage of Float Shorted Over Time

AbCellera Biologics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202416,640,000 shares $45.43 million -4.1%8.0%8.1 $2.73
10/15/202417,350,000 shares $44.42 million +1.7%8.4%9.4 $2.56
9/30/202417,060,000 shares $44.36 million +1.3%8.3%9.8 $2.60
9/15/202416,840,000 shares $46.31 million -4.1%8.2%9 $2.75
8/31/202417,550,000 shares $44.93 million -3.4%8.5%9.2 $2.56
8/15/202418,170,000 shares $47.61 million +4.3%8.8%10.7 $2.62
7/31/202417,420,000 shares $56.79 million -2.0%8.4%10.6 $3.26
7/15/202417,770,000 shares $56.86 million -5.4%8.6%10.7 $3.20
6/30/202418,780,000 shares $55.59 million -4.8%9.1%11.5 $2.96
6/15/202419,720,000 shares $63.70 million +7.1%9.6%13.1 $3.23
5/31/202418,420,000 shares $72.21 million -6.7%8.9%14.6 $3.92
5/15/202419,750,000 shares $73.08 million -15.2%9.6%14.6 $3.70
4/30/202423,290,000 shares $88.04 million +0.9%11.3%16.8 $3.78
4/15/202423,090,000 shares $96.52 million -2.1%11.3%17.4 $4.18
3/31/202423,590,000 shares $106.86 million +2.4%11.5%16.7 $4.53
3/15/202423,040,000 shares $108.52 million +1.1%11.2%16 $4.71
2/29/202422,780,000 shares $115.04 million -0.1%11.1%14.8 $5.05
2/15/202422,810,000 shares $120.44 million -6.9%11.4%14.6 $5.28
1/31/202424,490,000 shares $125.14 million -2.3%12.3%16.8 $5.11
1/15/202425,070,000 shares $135.13 million -2.0%12.6%16.6 $5.39
12/31/202325,580,000 shares $146.06 million -3.2%12.9%16.7 $5.71
12/15/202326,420,000 shares $143.46 million -2.2%13.3%16.9 $5.43
11/30/202327,000,000 shares $127.17 million -1.7%13.6%16.8 $4.71
11/15/202327,470,000 shares $124.44 million -1.2%13.9%17.8 $4.53
10/31/202327,810,000 shares $114.30 million +5.5%14.0%17 $4.11
10/15/202326,370,000 shares $112.34 million +2.5%13.4%15 $4.26
9/30/202325,720,000 shares $118.31 million +1.7%13.0%13.6 $4.60
9/15/202325,290,000 shares $135.05 million -4.2%12.8%12.4 $5.34
8/31/202326,390,000 shares $143.83 million -4.2%13.4%10 $5.45
8/15/202327,550,000 shares $152.08 million +4.3%14.0%9.2 $5.52
7/31/202326,410,000 shares $204.15 million +4.9%13.4%8.3 $7.73
7/15/202325,170,000 shares $180.22 million -0.3%12.8%8.1 $7.16
6/30/202325,240,000 shares $163.05 million -12.9%12.8%8.7 $6.46
6/15/202328,960,000 shares $216.62 million +11.5%14.7%10.3 $7.48
5/31/202325,970,000 shares $181.01 million -2.4%13.2%12 $6.97
5/15/202326,620,000 shares $159.19 million +8.5%13.5%13.5 $5.98
4/30/202324,530,000 shares $166.31 million +4.0%12.5%14.1 $6.78
4/15/202323,590,000 shares $174.09 million +0.1%12.0%14.9 $7.38
3/31/202323,560,000 shares $177.64 million +2.2%12.0%14.4 $7.54
3/15/202323,050,000 shares $171.26 million +4.0%11.8%13.6 $7.43
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

2/28/202322,170,000 shares $186.23 million +9.0%11.3%12 $8.40
2/15/202320,340,000 shares $202.99 million +6.3%10.5%10.9 $9.98
1/31/202319,130,000 shares $201.44 million -2.8%9.9%10.1 $10.53
1/15/202319,680,000 shares $204.28 million +29.9%10.1%9.8 $10.38
12/30/202215,150,000 shares $153.47 million -1.3%7.8%7.6 $10.13
12/15/202215,350,000 shares $159.64 million -7.0%7.9%7.6 $10.40
11/30/202216,510,000 shares $212.48 million -7.3%8.5%8.7 $12.87
11/15/202217,800,000 shares $257.92 million -2.4%9.2%10.3 $14.49
10/31/202218,230,000 shares $215.66 million -6.7%9.4%10 $11.83
10/15/202219,530,000 shares $201.94 million +0.6%10.1%11.1 $10.34
9/30/202219,410,000 shares $191.96 million -10.2%10.1%10.6 $9.89
9/15/202221,620,000 shares $235.23 million +7.8%11.6%9.6 $10.88
8/31/202220,050,000 shares $214.13 million +3.7%10.8%7.7 $10.68
8/15/202219,340,000 shares $261.86 million +1.0%10.4%7.2 $13.54
7/31/202219,140,000 shares $192.17 million -0.5%10.3%7 $10.04
7/15/202219,230,000 shares $202.68 million +0.2%10.3%7.3 $10.54
6/30/202219,200,000 shares $204.48 million +56.5%10.3%7.5 $10.65
6/15/202212,270,000 shares $113.74 million +13.9%6.6%4.9 $9.27
5/31/202210,770,000 shares $82.07 million -9.9%5.8%5.8 $7.62
5/15/202211,950,000 shares $86.40 million +2.0%6.4%6.5 $7.23
4/30/202211,720,000 shares $89.89 million -9.1%6.2%6.8 $7.67
4/15/202212,890,000 shares $115.88 million +7.2%6.9%6.8 $8.99
3/31/202212,030,000 shares $117.29 million +5.5%6.4%5.8 $9.75
3/15/202211,400,000 shares $88.58 million +8.5%6.1%5.6 $7.77
2/28/202210,510,000 shares $91.54 million -11.5%5.6%4.8 $8.71
2/15/202211,880,000 shares $118.56 million -2.5%6.4%5.5 $9.98
1/31/202212,190,000 shares $109.59 million -3.6%7.2%5.8 $8.99
1/15/202212,650,000 shares $127.13 million +19.7%7.6%6.4 $10.05
12/31/202110,570,000 shares $151.15 million +9.8%6.3%5.8 $14.30
12/15/20219,630,000 shares $125.09 million -14.2%5.8%4.9 $12.99
11/30/202111,220,000 shares $167.85 million +7.3%6.7%4.8 $14.96
11/15/202110,460,000 shares $171.44 million -1.4%6.3%4.5 $16.39
10/29/202110,610,000 shares $166.68 million +5.2%6.5%4.3 $15.71
10/15/202110,090,000 shares $156.70 million +24.3%6.2%4.2 $15.53
9/30/20218,120,000 shares $162.72 million +3.3%5.0%3.3 $20.04
9/15/20217,860,000 shares $147.85 million +1.6%4.8%3.3 $18.81
8/31/20217,740,000 shares $129.88 million -26.2%4.8%3.7 $16.78
8/13/202110,490,000 shares $187.67 million +22.7%6.6%5.1 $17.89
7/30/20218,550,000 shares $129.70 million +0.2%5.5%4.9 $15.17
7/15/20218,530,000 shares $141.00 million +1.8%5.3%5.3 $16.53
6/30/20218,380,000 shares $184.36 million +17.7%5.2%5.3 $22.00
6/15/20217,120,000 shares $167.53 million -6.1%4.5%4.7 $23.53
5/28/20217,580,000 shares $203.37 million -10.1%5.1%6.4 $26.83
5/14/20218,430,000 shares $287.80 million +31.9%5.6%7.9 $34.14
4/30/20216,390,000 shares $183.90 million +8.3%4.3%5.9 $28.78
4/15/20215,900,000 shares $166.68 million -4.8%3.9%5.6 $28.25
3/31/20216,200,000 shares $165.42 million +53.9%4.1%5.7 $26.68
3/15/20214,030,000 shares $147.26 million +79.9%2.7%4.4 $36.54
2/26/20212,240,000 shares $87.49 million -23.0%1.5%1.9 $39.06
2/12/20212,910,000 shares $133.86 million -37.3%2.0%2.4 $46.00
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

1/29/20214,640,000 shares $238.96 million -6.1%3.1%3.6 $51.50
1/15/20214,940,000 shares $230.40 million No Change3.2%3.4 $46.64

ABCL Short Interest - Frequently Asked Questions

What is AbCellera Biologics' current short interest?

Short interest is the volume of AbCellera Biologics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 16,640,000 shares of ABCL short. 8.04% of AbCellera Biologics' shares are currently sold short. Learn More on AbCellera Biologics' current short interest.

What is a good short interest ratio for AbCellera Biologics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABCL shares currently have a short interest ratio of 8.0. Learn More on AbCellera Biologics's short interest ratio.

Which institutional investors are shorting AbCellera Biologics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbCellera Biologics: National Bank of Canada FI. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for AbCellera Biologics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.04% of AbCellera Biologics' floating shares are currently sold short.

Is AbCellera Biologics' short interest increasing or decreasing?

AbCellera Biologics saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 16,640,000 shares, a drop of 4.1% from the previous total of 17,350,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is AbCellera Biologics' float size?

AbCellera Biologics currently has issued a total of 295,370,000 shares. Some of AbCellera Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AbCellera Biologics currently has a public float of 207,080,000 shares.

How does AbCellera Biologics' short interest compare to its competitors?

8.04% of AbCellera Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to AbCellera Biologics: HUTCHMED (China) Limited (0.33%), Agios Pharmaceuticals, Inc. (7.85%), Verona Pharma plc (9.41%), Dyne Therapeutics, Inc. (9.77%), Edgewise Therapeutics, Inc. (12.19%), Bausch Health Companies Inc. (3.59%), Xenon Pharmaceuticals Inc. (3.79%), Merus (12.65%), Vera Therapeutics, Inc. (13.31%), Amicus Therapeutics, Inc. (6.66%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short AbCellera Biologics stock?

Short selling ABCL is an investing strategy that aims to generate trading profit from AbCellera Biologics as its price is falling. ABCL shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AbCellera Biologics?

A short squeeze for AbCellera Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABCL, which in turn drives the price of the stock up even further.

How often is AbCellera Biologics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABCL, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:ABCL) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners